XML 18 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Reporting (Details) (USD $)
3 Months Ended
Mar. 31, 2014
type_of_transaction
segment
Mar. 31, 2013
Dec. 31, 2013
Segment reporting information      
Number of segments 3    
Net revenues $ 32,689,000,000 $ 30,751,000,000  
Gross profit 5,942,000,000 5,577,000,000  
Operating profit (loss) 2,024,000,000 1,694,000,000  
Total assets 72,822,000,000   71,526,000,000
Goodwill 28,139,000,000   26,542,000,000
Number of type of transactions related to intersegment eliminations 2    
Intersegment eliminations, intersegment revenues 1,100,000,000 939,000,000  
Pharmacy Services Segment
     
Segment reporting information      
Number of Centers of Excellence for Infusion and Enteral Services 6    
Number of states pharmacies operated 40    
Net revenues 20,195,000,000 [1] 18,311,000,000 [1]  
Gross profit 934,000,000 768,000,000  
Operating profit (loss) 640,000,000 499,000,000  
Total assets 40,365,000,000   38,343,000,000
Goodwill 21,250,000,000   19,658,000,000
Net revenues, retail co-payments 2,200,000,000 2,200,000,000  
Pharmacy Services Segment | Specialty stores
     
Segment reporting information      
Number of pharmacies 24    
Pharmacy Services Segment | Specialty mail order
     
Segment reporting information      
Number of pharmacies 11    
Pharmacy Services Segment | Mail service
     
Segment reporting information      
Number of pharmacies 4    
Pharmacy Services Segment | Infusion and Enteral Branches
     
Segment reporting information      
Number of Infusion and Enteral Branches 84    
Retail Pharmacy Segment
     
Segment reporting information      
Number of states pharmacies operated 43    
Number of retail drugstores 7,675    
Net revenues 16,480,000,000 16,039,000,000  
Gross profit 5,184,000,000 4,947,000,000  
Operating profit (loss) 1,750,000,000 1,532,000,000  
Total assets 30,960,000,000   30,191,000,000
Goodwill 6,889,000,000   6,884,000,000
Intersegment eliminations, intersegment gross profit 176,000,000 138,000,000  
Number of retail drugstores operating a pharmacy 7,615    
Retail Pharmacy Segment | MinuteClinic within CVS Pharmacy Stores
     
Segment reporting information      
Number of clinics in retail drugstores 820    
Retail Pharmacy Segment | MinuteClinic
     
Segment reporting information      
Number of clinics 828    
Retail Pharmacy Segment | Specialty stores
     
Segment reporting information      
Number of pharmacies 17    
Corporate Segment
     
Segment reporting information      
Net revenues 0 0  
Gross profit 0 0  
Operating profit (loss) (190,000,000) (199,000,000)  
Total assets 2,480,000,000   4,420,000,000
Goodwill 0   0
Intersegment Eliminations
     
Segment reporting information      
Net revenues (3,986,000,000) [2] (3,599,000,000) [2]  
Gross profit (176,000,000) [2] (138,000,000) [2]  
Operating profit (loss) (176,000,000) [2] (138,000,000) [2]  
Total assets (983,000,000) [2]   (1,428,000,000) [2]
Goodwill $ 0 [2]   $ 0 [2]
[1] Net revenues of the Pharmacy Services Segment include approximately $2.2 billion of retail co-payments for both of the three months ended March 31, 2014 and 2013
[2] Intersegment eliminations relate to two types of transactions: (i) Intersegment revenues that occur when Pharmacy Services Segment customers use Retail Pharmacy Segment stores to purchase covered products. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue on a stand-alone basis, and (ii) Intersegment revenues, gross profit and operating profit that occur when Pharmacy Services Segment customers, through the Company’s intersegment activities (such as the Maintenance Choice® program), elect to pick-up their maintenance prescriptions at Retail Pharmacy Segment stores instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue, gross profit and operating profit on a standalone basis. The following amounts are eliminated in consolidation in connection with the item (ii) intersegment activity above: net revenues of $1.1 billion and $939 million for the three months ended March 31, 2014 and 2013, respectively; and gross profit and operating profit of $176 million and $138 million for the three months ended March 31, 2014 and 2013, respectively.